Assignee
HOFFMANN LA ROCHE INC
US·9 granted patents·2 pending applications·16 citations·filing 2005–2025
Top patents by PatentIndex Score
11 records- 0195US11149083B2Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moietyHOFFMANN—LA ROCHE INC·Filed 2018·Granted Oct 19, 2021·12 cites·25 claims
- 0288US12596118B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE INC·Filed 2025·Granted Apr 7, 2026·0 cites·30 claims
- 0379US10183946B2Triazolo[4,5-D]pyrimidinesHOFFMANN—LA ROCHE INC·Filed 2017·Granted Jan 22, 2019·4 cites·18 claims
- 0479US2026098095A1Antibodies binding to hla-a2/mage-a4HOFFMANN LA ROCHE INC·Filed 2025·Application pending·0 cites
- 0563US12596120B2PH-gradient SPR-based binding assayHOFFMANN LA ROCHE INC·Filed 2021·Granted Apr 7, 2026·0 cites·7 claims
- 0663US12595255B2Heteroaryl-substituted imidazole derivativesHOFFMANN LA ROCHE INC·Filed 2023·Granted Apr 7, 2026·0 cites·25 claims
- 0762US12594240B2Artificial vitreous humor for the investigation of drugs and drug formulationsHOFFMANN LA ROCHE INC·Filed 2023·Granted Apr 7, 2026·0 cites·5 claims
- 0859US11732262B2Use of FUBP1 inhibitors for treating hepatitis B virus infectionHOFFMANN—LA ROCHE INC·Filed 2020·Granted Aug 22, 2023·0 cites·10 claims
- 0948US2026098271A1Method for increasing recombinant protein expressionHOFFMANN LA ROCHE INC·Filed 2025·Application pending·0 cites
- 1046US12595294B2Methods to decrease impurities from recombinant protein manufacturing processesHOFFMANN LA ROCHE INC·Filed 2022·Granted Apr 7, 2026·0 cites·15 claims
- 1144US7253318B2Benzyloxy derivatives as MAOB inhibitorsHOFFMANN-LA ROCHE INC.·Filed 2005·Granted Aug 7, 2007·0 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →